Which administration route is used for Angiomax?

Angiomax, also known as bivalirudin, is an anticoagulant medication primarily used in the context of percutaneous coronary intervention procedures, specifically for patients undergoing angioplasty. The correct administration route for Angiomax is intravenous.

The intravenous route allows for rapid onset of action, which is crucial in emergency settings where immediate anticoagulation is needed to prevent thrombus formation during surgical procedures. This route also enables precise control over drug levels in the bloodstream and is commonly used for medications that require careful monitoring or have quick effects.

In contrast, the oral route is not suitable for Angiomax because the medication's effectiveness relies on immediate bioavailability and rapid pharmacological action. Subcutaneous administration is typically used for medications that require gradual absorption, which does not match the needs of patients receiving Angiomax. Topical application is also not appropriate, as Angiomax is not designed to be absorbed through the skin and is ineffective when applied in this manner.